KORU Medical Systems (KRMD) Cash from Financing Activities (2010 - 2026)
KORU Medical Systems' (KRMD) quarterly Cash from Financing Activities came in at -$29216.0 in Q1 2026, up 81.83% year-on-year from -$16067.6 in Q1 2025, and up 88.97% on a QoQ basis from -$264908.0 in Q4 2025.
KORU Medical Systems (KRMD) Cash from Financing Activities (2010 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has 11 years of Cash from Financing Activities data on file, last reported at -$29216.0 in Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 81.83% year-over-year to -$29216.0 in Q1 2026; TTM through Mar 2026 was -$89758.0, a 60.5% increase from a year earlier, with the FY2025 full-year figure at -$221350.0, up 10.94% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$29216.0, up from -$264908.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for KRMD reached as high as $940282.0 in Q3 2022 and fell as low as -$264908.0 in Q4 2025.
- Historically, Cash from Financing Activities has averaged -$25793.0 across 5 years, with a median of -$182120.0 in 2024.
- Across the five-year window, Cash from Financing Activities tumbled 32154.12% in 2022 and surged 81.83% in 2026, its largest moves.
- Year by year, Cash from Financing Activities stood at -$145603.0 in 2022, then fell by 22.49% to -$178355.0 in 2023, then fell by 20.95% to -$215716.0 in 2024, then retreated by 22.8% to -$264908.0 in 2025, then jumped by 88.97% to -$29216.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$29216.0 in Q1 2026, -$264908.0 in Q4 2025, and $396330.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | KORU Medical Systems | 172.94 Mn | 164.14 Mn | 7.23 Mn | -29,216.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29,216.00 |
| Mar 31, 2026 | -29,216.00 |
| Dec 31, 2025 | -264,908.00 |
| Dec 31, 2025 | -264,908.00 |
| Sep 30, 2025 | 396,330.00 |
| Sep 30, 2025 | 396,330.00 |
| Jun 30, 2025 | -191,964.00 |
| Jun 30, 2025 | -191,964.00 |
| Mar 31, 2025 | -160,808.00 |
| Mar 31, 2025 | -160,808.00 |
| Dec 31, 2024 | -215,716.00 |
| Dec 31, 2024 | -215,716.00 |
| Sep 30, 2024 | 374,454.00 |
| Sep 30, 2024 | 374,454.00 |
| Jun 30, 2024 | -225,151.00 |
| Jun 30, 2024 | -225,151.00 |
| Mar 31, 2024 | -182,120.00 |
| Mar 31, 2024 | -182,120.00 |
| Dec 31, 2023 | -178,355.00 |
| Dec 31, 2023 | -178,355.00 |